Patents by Inventor Seok Mo KIM

Seok Mo KIM has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250085674
    Abstract: Provided are a scalable analog passive intermodulation (PIM) module, a method of controlling analog PIM, a signal processing circuit, and a sensor device. The scalable analog PIM module includes a first plural number of digital-to-analog converters (DACs), a first plural number of static random access memory (SRAM) calculators connected to the first plural number of DACs, at least one analog-to-digital converter (ADC) connected to the first plural number of SRAM calculators and configured to convert an analog convolution result signal into digital convolution data, and an analog PIM controller configured to output an enable control signal for enabling a second number, which is equal to or less than first plural number, of SRAM calculators among the first plural number of SRAM calculators to the first plural number of SRAM calculators on the basis of the convolution data output from the ADC.
    Type: Application
    Filed: November 22, 2024
    Publication date: March 13, 2025
    Applicants: SKAIChips Co., Ltd., Research & Business Foundation SUNGKYUNKWAN UNIVERSITY
    Inventors: Kang Yoon LEE, Jong Wan JO, Sung June BYUN, Dae Young CHOI, Young Gun PU, Joon Mo YOO, Yeon Jae JUNG, Hyung Ki HUH, Seok Kee KIM
  • Patent number: 12139491
    Abstract: The present invention relates to a novel compound and a pharmaceutical composition for enhancing anticancer activity, which includes the same, and more particularly, to a pharmaceutical composition, which includes a compound represented by Formula 1 or a pharmaceutically acceptable salt thereof, thereby enhancing anticancer activity of an anticancer agent or radiation, and inducing proliferation inhibition and death of cancer cells, resulting in effectively treating cancer:
    Type: Grant
    Filed: December 27, 2019
    Date of Patent: November 12, 2024
    Assignee: HOLOSMEDIC
    Inventors: Ki Cheong Park, Jae Ho Cheong, Seok Mo Kim, Yeo Jin Yun, Byeong Mo Kim
  • Publication number: 20220064171
    Abstract: The present invention relates to a novel compound and a pharmaceutical composition for enhancing anticancer activity, which includes the same, and more particularly, to a pharmaceutical composition, which includes a compound represented by Formula 1 or a pharmaceutically acceptable salt thereof, thereby enhancing anticancer activity of an anticancer agent or radiation, and inducing proliferation inhibition and death of cancer cells, resulting in effectively treating cancer:
    Type: Application
    Filed: December 27, 2019
    Publication date: March 3, 2022
    Inventors: Ki Cheong PARK, Jae Ho CHEONG, Seok Mo KIM, Yeo Jin YUN, Byeong Mo KIM